FENC
Price
$7.86
Change
-$0.11 (-1.38%)
Updated
May 23, 04:59 PM (EDT)
Capitalization
221.36M
75 days until earnings call
PEPG
Price
$1.46
Change
+$0.02 (+1.39%)
Updated
May 23, 04:59 PM (EDT)
Capitalization
48.1M
75 days until earnings call
Interact to see
Advertisement

FENC vs PEPG

Header iconFENC vs PEPG Comparison
Open Charts FENC vs PEPGBanner chart's image
Fennec Pharmaceuticals
Price$7.86
Change-$0.11 (-1.38%)
Volume$1.52K
Capitalization221.36M
PepGen
Price$1.46
Change+$0.02 (+1.39%)
Volume$1.72K
Capitalization48.1M
FENC vs PEPG Comparison Chart
Loading...
FENC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PEPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FENC vs. PEPG commentary
May 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FENC is a Hold and PEPG is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 24, 2025
Stock price -- (FENC: $7.97 vs. PEPG: $1.47)
Brand notoriety: FENC and PEPG are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FENC: 109% vs. PEPG: 82%
Market capitalization -- FENC: $221.36M vs. PEPG: $48.1M
FENC [@Biotechnology] is valued at $221.36M. PEPG’s [@Biotechnology] market capitalization is $48.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $307B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FENC’s FA Score shows that 0 FA rating(s) are green whilePEPG’s FA Score has 1 green FA rating(s).

  • FENC’s FA Score: 0 green, 5 red.
  • PEPG’s FA Score: 1 green, 4 red.
According to our system of comparison, both FENC and PEPG are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FENC’s TA Score shows that 6 TA indicator(s) are bullish while PEPG’s TA Score has 2 bullish TA indicator(s).

  • FENC’s TA Score: 6 bullish, 4 bearish.
  • PEPG’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, FENC is a better buy in the short-term than PEPG.

Price Growth

FENC (@Biotechnology) experienced а +21.68% price change this week, while PEPG (@Biotechnology) price change was +2.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.07%. For the same industry, the average monthly price growth was +3.12%, and the average quarterly price growth was -3.91%.

Reported Earning Dates

FENC is expected to report earnings on Aug 07, 2025.

PEPG is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+1.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FENC($221M) has a higher market cap than PEPG($48.1M). FENC YTD gains are higher at: 26.108 vs. PEPG (-61.214). FENC has higher annual earnings (EBITDA): 3.02M vs. PEPG (-92.49M). PEPG has more cash in the bank: 120M vs. FENC (40.3M). PEPG has less debt than FENC: PEPG (18.7M) vs FENC (32.1M). FENC has higher revenues than PEPG: FENC (49.3M) vs PEPG (0).
FENCPEPGFENC / PEPG
Capitalization221M48.1M459%
EBITDA3.02M-92.49M-3%
Gain YTD26.108-61.214-43%
P/E Ratio60.43N/A-
Revenue49.3M0-
Total Cash40.3M120M34%
Total Debt32.1M18.7M172%
FUNDAMENTALS RATINGS
FENC: Fundamental Ratings
FENC
OUTLOOK RATING
1..100
28
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
PROFIT vs RISK RATING
1..100
87
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
39

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FENCPEPG
RSI
ODDS (%)
Bearish Trend 2 days ago
75%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 8 days ago
87%
Declines
ODDS (%)
Bearish Trend 18 days ago
79%
Bearish Trend 17 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
FENC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PEPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME30.862.81
+10.02%
GameStop Corp
TSLA341.046.42
+1.92%
Tesla
BTC.X111673.2800001995.203100
+1.82%
Bitcoin cryptocurrency
SPY583.090.23
+0.04%
SPDR® S&P 500® ETF
AAPL201.36-0.73
-0.36%
Apple

FENC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FENC has been loosely correlated with ONPPF. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if FENC jumps, then ONPPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FENC
1D Price
Change %
FENC100%
-3.86%
ONPPF - FENC
48%
Loosely correlated
N/A
CLDX - FENC
44%
Loosely correlated
N/A
EYPT - FENC
43%
Loosely correlated
-4.60%
IDYA - FENC
43%
Loosely correlated
N/A
ATXS - FENC
42%
Loosely correlated
+4.08%
More

PEPG and

Correlation & Price change

A.I.dvisor indicates that over the last year, PEPG has been loosely correlated with SLDB. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if PEPG jumps, then SLDB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PEPG
1D Price
Change %
PEPG100%
+2.08%
SLDB - PEPG
36%
Loosely correlated
+7.04%
MGNX - PEPG
35%
Loosely correlated
+6.04%
FENC - PEPG
31%
Poorly correlated
-3.86%
XNCR - PEPG
31%
Poorly correlated
+2.26%
IMTX - PEPG
30%
Poorly correlated
+1.56%
More